Fred Grossman serves as Chief Medical Officer at Coya Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Fred Grossman has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 22, 2026 involved receiving (via award) 140,041 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 22, 2026 | COYA | $0 | Award | 140,041 | $N/A | Discretionary |
Fred Grossman currently holds 140,041 shares of Coya Therapeutics, Inc. (COYA), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Fred Grossman has been a net neutral trader of COYA stock. They have purchased $0 and sold $0 worth of shares.
Fred Grossman's most recent insider trade was on Jan 22, 2026, when they sold 140,041 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted